## **Core Concept**
The Revised National Tuberculosis Control Programme (RNTCP) in India, now known as the National Tuberculosis Elimination Programme (NTEP), follows the World Health Organization (WHO) guidelines for the treatment and management of tuberculosis (TB). Sputum examination is a critical component of TB diagnosis and treatment monitoring. Category I patients typically include new smear-positive pulmonary TB patients, new smear-negative pulmonary TB patients with extensive lung involvement, and patients with severe forms of extrapulmonary TB.

## **Why the Correct Answer is Right**
The correct schedule for sputum examination after beginning chemotherapy in Category I patients, as per RNTCP guidelines, is at the end of the intensive phase, which is usually after 2 months of treatment. This is crucial for assessing the treatment response. If the sputum smear is still positive after 2 months, the patient may require an extended intensive phase or a change in treatment regimen.

## **Why Each Wrong Option is Incorrect**
- **Option A:** This option does not align with standard RNTCP guidelines for sputum examination follow-up.
- **Option B:** This option suggests a follow-up that is too early or not standard for assessing treatment response in Category I patients.
- **Option C:** This option does not match the recommended schedule for sputum examination after starting chemotherapy.
- **Option D:** This option is correct as per RNTCP guidelines; hence, it is not incorrect but the correct answer.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that sputum smear microscopy is performed at the end of the intensive phase (2 months) and at the end of treatment (6 months) for Category I patients. This helps in assessing the treatment outcome and deciding on further management.

## **Correct Answer:** .